£10.2M
The seed round was co-led by Octopus Ventures and redalpine to support preclinical candidate selection and pipeline development.
ExpressionEdits
ExpressionEdits uses artificial intelligence and proprietary intron technology to optimise protein expression.
£10.2MTotal raised
ExpressionEdits develops a computational gene editing platform that uses artificial intelligence and proprietary intron technology to optimise protein expression. The biotechnology firm operates from its headquarters in Cambridge.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from ExpressionEdits's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
KT